Interleukin-6 May Boost Prediction of Obesity-Related Cancers
TUESDAY, Sept. 3, 2024 (HealthDay News) -- In patients with newly diagnosed type 2 diabetes, baseline interleukin-6 (IL-6) levels may enhance prediction of new-onset obesity-related cancers, according to a study scheduled to be presented at the annual meeting of...